Clinical trial
Citrulline: A Plasmatic Marker to Assess and Monitor Small Bowel Crohn's Disease…
NCT00138879 · St Mark's Hospital Foundation, Other · Completed
Key facts
| NCT number | NCT00138879 |
|---|---|
| Title | Citrulline: A Plasmatic Marker to Assess and Monitor Small Bowel Crohn's Disease Patients |
| Official title | Plasma Citrulline Level: A Simple, Sensitive Method to Assess and Monitor Small Bowel Absorptive Function in Patients With Crohn's Disease? |
| Lead sponsor | St Mark's Hospital Foundation, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Crohn's Disease, Short Bowel Syndrome, Malabsorption Syndromes, Celiac Disease |
| Enrollment | 54 |
| Start date | May 1, 2003 |
| Completion | Jun 1, 2005 |
| First posted | Aug 30, 2005 |
| Last update posted | Dec 15, 2005 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: